Need for involving consumers in Nepal's pharmacovigilance system

被引:10
|
作者
Jha, Nisha [1 ]
Rathore, Devendra Singh [2 ]
Shankar, P. Ravi [3 ]
Thapa, Bhupendra Bahadur [4 ]
Bhuju, Gajendra [5 ]
Alshakka, Mohammed [6 ]
机构
[1] KIST Med Coll, Patan, Nepal
[2] LR Inst Pharm, Solan, Himachal Prades, India
[3] Xavier Univ, Sch Med, Oranjestad, Aruba
[4] Minist Hlth & Populat, Kathmandu, Nepal
[5] Dept Drug Adm, Kathmandu, Nepal
[6] Aden Univ, Fac Pharm, Aden, Yemen
来源
AUSTRALASIAN MEDICAL JOURNAL | 2014年 / 7卷 / 04期
关键词
Consumers; Nepal; pharmacovigilance;
D O I
10.4066/AMJ.2014.2011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In Nepal, reporting of adverse drug reactions (ADRs) occurs on a voluntary basis by doctors, pharmacists, nurses, health assistants, and other healthcare professionals. The country's pharmacovigilance program is still in its infancy; it has limited coverage and underreporting is common. This major limitation could be reduced with consumer involvement. This report examines the necessity and benefits of consumer involvement in Nepal's existing pharmacovigilance program, reflecting on existing examples of consumer pharmacovigilance in different countries to highlight the necessity for such a framework in Nepal.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 50 条
  • [2] Pharmacovigilance Activities in Nepal
    Subish Palaian
    Mohamed Izham Mohamed Ibrahim
    Pranaya Mishra
    Kadir Alam
    Pathiyil Ravi Shankar
    Bhupendra Bahadur Thapa
    [J]. Drug Safety, 2010, 33 : 889 - 890
  • [3] Pharmacovigilance Activities in Nepal
    Palaian, Subish
    Ibrahim, Mohamed Izham Mohamed
    Mishra, Pranaya
    Alam, Kadir
    Shankar, Pathiyil Ravi
    Thapa, Bhupendra Bahadur
    [J]. DRUG SAFETY, 2010, 33 (10) : 889 - 890
  • [4] Assessment of the national pharmacovigilance system in Nepal using the indicator based pharmacovigilance assessment tool (IPAT)
    Jha, Nisha
    Palaian, Subish
    Shankar, Pathiyil Ravi
    Santosh, K. C.
    Kshetri, Pan Bahadur
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 147 - 148
  • [5] The need for pharmacovigilance
    Olsson, S
    [J]. PHARMACOLOGY AND THERAPEUTICS IN THE NEW MILLENNIUM, 2001, : 502 - 508
  • [6] Strengthening the Pharmacovigilance Programme in Nepal
    Santosh, K. C.
    Tragulpiankit, P.
    Gorsanan, P.
    Edwards, I. R.
    Alam, K.
    [J]. NEPAL JOURNAL OF EPIDEMIOLOGY, 2013, 3 (01): : 230 - 235
  • [7] Situation analysis of the pharmacovigilance system in Nepal using the indicator-based pharmacovigilance assessment tool (IPAT)
    Jha, Nisha
    Palaian, Subish
    Shankar, Pathiyil Ravi
    Santosh, K. C.
    Kshetry, Pan Bahadur
    [J]. JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2021, 12 (04) : 485 - 491
  • [8] Need of Medical Education System Reform in Nepal
    Magar, Angel
    [J]. JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2013, 52 (07) : I - II
  • [9] The need for definitions in pharmacovigilance
    Lindquist, Marie
    [J]. DRUG SAFETY, 2007, 30 (10) : 825 - 830
  • [10] Pharmacovigilance in Nepal: Whose baby is it anyway?
    Shankar, P. R.
    [J]. AUSTRALASIAN MEDICAL JOURNAL, 2013, 6 (03): : 132 - 133